karen reckamp, md, ms: results in phase ii advanced lung cancer trial
Published 11 years ago • 402 plays • Length 5:51Download video MP4
Download video MP3
Similar videos
-
22:53
paradigm changes in the perioperative setting for non-small cell lung cancer - karen reckamp, md
-
34:23
management of non-small cell lung cancer (nsclc) with an egfr mutation — karen reckamp, md, ms
-
0:59
dr. karen reckamp evaluates the predictive efficacy of the veristrat in nsclc
-
1:02
dr. reckamp on mk-2206 for the treatment of egfr wild-type nsclc
-
4:18
symptoms that may be lung cancer
-
3:41
a physician faces stage iv #kidneycancer: his advice for you
-
44:18
advances in immunotherapy clinical trials: putting patients first
-
7:31
lecia v. sequist, md, mph: lung cancer genomics
-
1:11
dr. reckamp on targeted therapy options for rare mutations in nsclc
-
1:25
the current approach to managing patients with prefibrotic pmf
-
0:49
dr. reckamp on molecular testing in lung cancer
-
9:04
ramesh rengan, md, phd: radiation oncology advances and lung cancer treatment
-
4:09
joan schiller, md: understanding women and lung cancer
-
2:10
dr linscott on the need for improved mrd detection in high-risk nmibc
-
2:14
reckamp immunotherapy for previously treated patients with nsclc
-
2:24
dr. reckamp on met-targeting strategies in nsclc
-
3:17
as kidney cancer rates rise, new treatment option may help some patients with advanced disease
-
1:51
treatment schedule for ruxolitinib in patients with mpns and how to assess response
-
1:07:18
cardiac complications of emerging cancer therapeutics
-
5:26
why do we focus specifically on stage 4 cancer